Last 7 days
14.4%
Last 30 days
57.6%
Last 90 days
-44.8%
Trailing 12 Months
-24.3%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-15 | Machiels Alec | sold | -56,675 | 45.34 | -1,250 | - |
2023-09-15 | Machiels Alec | acquired | 3,337 | 2.67 | 1,250 | - |
2023-09-14 | Chopas James George | acquired | - | - | 2,500 | vp/chief accounting officer |
2023-09-08 | Deschatelets Pascal | acquired | 49,395 | 2.67 | 18,500 | chief scientific officer |
2023-09-08 | Deschatelets Pascal | sold | -514,440 | 42.87 | -12,000 | chief scientific officer |
2023-09-06 | SCHEIBLER LUKAS | sold | -75,525 | 43.01 | -1,756 | chief research officer |
2023-09-01 | Francois Cedric | sold | -6,262,960 | 41.7531 | -150,000 | chief executive officer |
2023-09-01 | Francois Cedric | acquired | 801,000 | 2.67 | 300,000 | chief executive officer |
2023-08-31 | Chopas James George | sold | -22,715 | 41.226 | -551 | vp/chief accounting officer |
2023-08-08 | Deschatelets Pascal | acquired | 49,395 | 2.67 | 18,500 | chief scientific officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-12 | Farther Finance Advisors, LLC | unchanged | - | 327 | 1,184 | -% |
2023-08-24 | Alberta Investment Management Corp | sold off | -100 | -264,829 | - | -% |
2023-08-24 | PERCEPTIVE ADVISORS LLC | added | 46.22 | 37,346,100 | 73,976,600 | 2.14% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | reduced | -37.04 | -92,888 | 619,480 | 0.01% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -65.1 | -486,438 | 452,409 | -% |
2023-08-21 | Affinity Asset Advisors, LLC | reduced | -71.43 | -1,397,600 | 911,000 | 0.32% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | reduced | -57.25 | -1,479,000 | 2,131,000 | 0.02% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -7.21 | 2,091,470 | 9,518,770 | 0.01% |
2023-08-18 | Legato Capital Management LLC | added | 27.31 | 348,180 | 807,328 | 0.11% |
2023-08-17 | Orion Portfolio Solutions, LLC | reduced | -3.71 | 377,064 | 1,519,820 | 0.02% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Sep 08, 2023 | wellington management group llp | 12.55% | 14,770,859 | SC 13G/A | |
Jul 18, 2023 | ecor1 capital, llc | 5.4% | 6,307,547 | SC 13G | |
Jul 07, 2023 | blackrock inc. | 4.9% | 5,747,184 | SC 13G/A | |
Feb 14, 2023 | t. rowe price investment management, inc. | 5.3% | 5,842,660 | SC 13G | |
Feb 14, 2023 | avoro capital advisors llc | 9.6% | 10,625,000 | SC 13G/A | |
Feb 14, 2023 | price t rowe associates inc /md/ | 2.5% | 2,749,542 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 8.33% | 9,212,491 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 7.98% | 8,820,398 | SC 13G/A | |
Feb 01, 2023 | blackrock inc. | 7.0% | 7,704,194 | SC 13G/A | |
Feb 14, 2022 | morningside venture investments ltd | 13.2% | 12,806,342 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 19, 2023 | 4 | Insider Trading | |
Sep 19, 2023 | 4 | Insider Trading | |
Sep 18, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 18, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 18, 2023 | 4 | Insider Trading | |
Sep 18, 2023 | 4 | Insider Trading | |
Sep 15, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 11, 2023 | 4 | Insider Trading | |
Sep 08, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 08, 2023 | SC 13G/A | Major Ownership Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
BGNE | 287.4B | 1.8B | 8.19% | 34.91% | -165.92 | 158.74 | 69.45% | 14.65% |
ABBV | 271.2B | 56.0B | 2.23% | 8.69% | 31.23 | 4.84 | -2.31% | -31.27% |
VRTX | 92.4B | 9.5B | 3.90% | 25.64% | 27.45 | 9.72 | 13.83% | 5.33% |
REGN | 89.5B | 12.7B | 3.00% | 16.97% | 20.83 | 7.07 | -10.94% | -24.40% |
ALNY | 21.9B | 1.2B | -5.57% | -18.68% | -20.63 | 17.73 | 39.94% | -8.44% |
SRPT | 11.1B | 1.0B | 6.45% | 3.35% | -12.24 | 11.07 | 20.15% | -79.16% |
UTHR | 10.4B | 2.1B | -3.97% | 1.74% | 11.88 | 4.9 | 18.01% | 38.16% |
MID-CAP | ||||||||
MDGL | 3.1B | - | -5.78% | 157.92% | -9.48 | - | - | -28.88% |
BPMC | 3.1B | 225.6M | 4.14% | -26.79% | -5.62 | 13.8 | -2.11% | 21.02% |
RARE | 2.6B | 402.9M | 3.70% | -20.53% | -3.61 | 6.46 | 20.50% | -42.46% |
MRTX | 1.9B | 27.2M | -16.17% | -58.23% | -2.56 | 69.33 | - | -14.43% |
SMALL-CAP | ||||||||
CYTK | 3.1B | - | 1.51% | -37.05% | -7.31 | 33.28 | 34.30% | -149.91% |
CPRX | 1.4B | 302.9M | -11.98% | -2.00% | 11.71 | 4.47 | 77.72% | 112.02% |
MGNX | 283.7M | 152.5M | -7.29% | 31.99% | 38.08 | 1.86 | 127.84% | 103.41% |
CRBP | 30.6M | - | -1.14% | 3544.51% | -0.66 | - | - | -31.51% |
19.3%
14.0%
100%
74.6%
55.4%
Y-axis is the maximum loss one would have experienced if Apellis Pharmaceuticals was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 74.3% | 184,534,000 | 105,887,000 | 75,422,000 | 113,049,000 | 96,643,000 | 80,944,000 | 66,563,000 | 112,583,750 | 158,604,500 | 204,625,250 | 250,646,000 | 128,383,390 | 6,120,779 | 6,516,779 | 5,108,779 | 5,121,814 | 4,638,239 | 4,004,904 | 2,960,771 | 2,728,655 | 2,376,132 |
Operating Expenses | 6.8% | 797,049,000 | 746,585,000 | 670,035,000 | 633,013,000 | 591,664,000 | 621,628,000 | 602,840,000 | 573,025,000 | 569,578,000 | 490,176,000 | 464,372,000 | 468,861,333 | 388,528,000 | - | 288,015,000 | 279,792,000 | - | - | 127,925,000 | - | - |
S&GA Expenses | 14.7% | 376,240,000 | 328,070,000 | 277,163,000 | 234,258,000 | 201,615,000 | 187,379,000 | 176,771,000 | 179,801,000 | 171,029,000 | 150,476,000 | 139,401,000 | 122,377,000 | 104,015,000 | 88,379,000 | 67,046,000 | 45,968,797 | 33,604,922 | 26,774,745 | 22,639,000 | 21,108,164 | 16,914,476 |
R&D Expenses | -1.5% | 400,315,000 | 406,318,000 | 387,236,000 | 365,994,000 | 358,520,000 | 352,802,000 | 345,869,000 | 318,025,000 | 323,499,000 | 314,650,000 | 299,921,000 | 328,055,000 | 286,167,000 | 249,771,000 | 220,969,000 | 173,303,035 | 151,523,491 | 128,363,110 | 105,286,000 | 87,612,818 | 67,591,244 |
EBITDA | 100.0% | - | -686,390,000 | -644,948,000 | -625,082,000 | -628,220,000 | -705,630,000 | -734,358,000 | -794,162,000 | -788,526,000 | -327,036,000 | -330,100,000 | -291,749,994 | -300,619,473 | -300,479,000 | -303,720,000 | - | - | - | - | - | - |
EBITDA Margin | 100.0% | - | -6.48 | -8.55 | -5.53 | -6.50 | -8.65 | -11.03 | -7.05 | -4.97 | -1.60 | -1.32 | -2.27 | -49.12 | -46.11 | -59.45 | - | - | - | - | - | - |
Interest Expenses | 0% | 3,286,000 | 3,286,000 | 5,003,000 | 5,003,000 | 6,732,000 | 6,732,000 | 10,265,000 | 10,265,000 | 15,993,000 | 15,993,000 | 12,929,000 | 12,957,000 | 4,088,000 | 4,228,000 | 987,000 | 1,436,306 | 1,535,722 | 1,852,250 | 1,816,000 | 1,338,694 | 1,344,371 |
Earnings Before Taxes | 4.9% | -657,624,000 | -691,272,000 | -651,503,000 | -631,622,000 | -636,370,000 | -700,070,000 | -746,002,000 | -797,894,666 | -805,700,000 | -734,636,000 | -343,029,000 | - | - | - | -304,707,000 | - | - | - | -127,502,000 | - | - |
EBT Margin | 100.0% | - | -6.53 | -8.64 | -5.59 | -6.58 | -8.75 | -11.21 | -7.16 | -5.08 | -1.68 | -1.37 | -2.37 | -49.79 | -46.76 | -59.64 | - | - | - | - | - | - |
Net Income | 4.9% | -657,075,000 | -691,015,000 | -652,172,000 | -634,114,000 | -638,416,000 | -701,630,000 | -746,354,000 | -520,156,000 | -460,285,000 | -359,711,000 | -344,874,000 | -536,357,000 | -470,482,000 | -422,955,000 | -304,707,000 | -227,948,475 | -194,095,590 | -156,339,890 | -127,502,194 | -109,298,615 | -84,899,773 |
Net Income Margin | 100.0% | - | -6.53 | -8.65 | -5.61 | -6.61 | -8.60 | -11.21 | -4.62 | -2.90 | -1.76 | -1.38 | -4.18 | -76.87 | -64.90 | -59.64 | - | - | - | - | - | - |
Free Cashflow | 100.0% | - | -581,502,000 | -515,269,000 | -486,192,000 | -500,556,000 | -522,077,000 | -564,229,000 | -310,443,000 | -245,028,000 | -210,924,000 | -165,910,000 | -389,404,238 | -339,910,389 | -285,176,516 | -212,828,000 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -6.5% | 916 | 979 | 760 | 873 | 1,002 | 1,146 | 882 | 526 | 700 | 810 | 961 | 768 | 870 | 689 | 389 | 466 | 317 | 318 | 204 | 239 | 267 |
Current Assets | -6.5% | 893 | 954 | 720 | 832 | 960 | 1,104 | 824 | 475 | 655 | 774 | 917 | 742 | 854 | 672 | 373 | 451 | 308 | 311 | 202 | 239 | 267 |
Cash Equivalents | -19.5% | 616 | 765 | 552 | 584 | 604 | 633 | 642 | 284 | 271 | 265 | 566 | 416 | 317 | 418 | 352 | 434 | 289 | 288 | 176 | 221 | 254 |
Inventory | 20.7% | 103 | 85.00 | 86.00 | 60.00 | 48.00 | 33.00 | 16.00 | 2.00 | 4.00 | - | - | - | - | - | - | - | - | - | - | - | - |
Net PPE | -10.5% | 5.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | - | - |
Liabilities | 0.6% | 570 | 567 | 590 | 565 | 668 | 684 | 683 | 583 | 841 | 758 | 756 | 662 | 638 | 430 | 355 | 327 | 158 | 94.00 | 43.00 | 43.00 | 37.00 |
Current Liabilities | 26.1% | 175 | 139 | 168 | 115 | 127 | 125 | 132 | 94.00 | 158 | 84.00 | 128 | 75.00 | 58.00 | 51.00 | 66.00 | 45.00 | 36.00 | 20.00 | 17.00 | 16.00 | 10.00 |
Shareholder's Equity | -16.2% | 345 | 412 | 170 | 307 | 334 | 462 | 199 | - | - | 52.00 | 205 | 106 | 232 | 259 | 34.00 | 140 | 159 | 225 | 161 | 196 | 230 |
Retained Earnings | -4.9% | -2,608 | -2,486 | -2,308 | -2,142 | -1,951 | -1,795 | -1,656 | -1,508 | -1,313 | -1,093 | -926 | -1,004 | -868 | -750 | -581 | -468 | -398 | -327 | -276 | -240 | -204 |
Additional Paid-In Capital | 1.9% | 2,955 | 2,900 | 2,480 | 2,453 | 2,289 | 2,260 | 1,857 | 1,453 | 1,174 | 1,147 | 1,131 | 1,112 | 1,101 | 1,008 | 616 | 608 | 558 | 552 | 438 | 436 | 434 |
Shares Outstanding | 1.2% | 118 | 116 | 111 | 110 | 107 | 106 | 98.00 | 87.00 | 81.00 | 79.00 | 76.00 | 75.00 | 75.00 | 74.00 | 62.00 | 64.00 | 64.00 | 63.00 | 54.00 | 54.00 | 55.00 |
Cashflow (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -7.4% | -622,936,000 | -579,805,000 | -513,745,000 | -485,500,000 | -499,708,000 | -521,372,000 | -563,126,000 | -308,648,000 | -239,847,000 | -205,453,000 | -160,488,000 | -384,538,000 | -338,311,000 | -283,924,000 | -211,135,000 | -173,542,426 | -153,077,874 | -143,865,751 | -131,241,000 | -102,295,378 | -80,300,798 |
Share Based Compensation | 6.8% | 105,883,000 | 99,135,000 | 91,085,000 | 86,156,000 | 79,809,000 | 75,001,000 | 70,667,000 | 63,849,000 | 58,754,000 | 52,521,000 | 45,376,000 | 39,989,000 | 33,185,000 | 25,879,000 | 21,144,000 | 15,865,361 | 12,621,285 | 10,681,812 | 7,733,000 | 10,068,979 | 8,563,592 |
Cashflow From Investing | -25.1% | 248,282,000 | 331,583,000 | 59,893,000 | 20,744,000 | 75,609,000 | 122,432,000 | 247,616,000 | 162,545,000 | 181,659,000 | -235,900,000 | -316,989,000 | -317,053,000 | -516,287,000 | -228,672,000 | -1,693,000 | -2,050,666 | -2,134,000 | -3,500,000 | - | - | - |
Cashflow From Financing | 1.7% | 386,356,000 | 380,061,000 | 365,659,000 | 765,563,000 | 758,047,000 | 767,308,000 | 392,236,000 | 14,595,000 | 13,401,000 | 290,543,000 | 692,178,000 | 686,070,000 | 884,094,000 | 643,390,000 | 388,541,000 | 388,447,297 | 189,458,863 | 280,098,303 | 131,903,000 | 309,828,188 | 413,155,496 |
Condensed Consolidated Statements of Operations and Comprehensive Income/(Loss) (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenue: | ||||
Revenue | $ 94,969 | $ 16,322 | $ 139,814 | $ 30,703 |
Operating expenses: | ||||
Cost of sales | 8,379 | 82 | 16,188 | 1,329 |
Research and development | 95,658 | 101,661 | 205,684 | 192,606 |
General and administrative | 111,373 | 63,203 | 213,466 | 114,390 |
Total operating expenses: | 215,410 | 164,946 | 435,338 | 308,325 |
Net operating loss | (120,441) | (148,624) | (295,524) | (277,622) |
Interest income | 6,002 | 1,432 | 11,395 | 1,530 |
Interest expense | (7,341) | (8,448) | (14,869) | (16,986) |
Other (expense)/income, net | (63) | 149 | (341) | (140) |
Net loss before taxes | (121,843) | (155,491) | (299,339) | (293,218) |
Income tax expense | 194 | 486 | 476 | 1,694 |
Net loss | (122,037) | (155,977) | (299,815) | (294,912) |
Other comprehensive gain/(loss): | ||||
Unrealized gain/(loss) on marketable securities | (766) | (818) | ||
Foreign currency gain | (21) | (369) | 79 | (286) |
Total other comprehensive income/(loss) | (21) | (1,135) | 79 | (1,104) |
Comprehensive loss, net of tax | $ (122,058) | $ (157,112) | $ (299,736) | $ (296,016) |
Net loss per common share, basic | $ (1.02) | $ (1.46) | $ (2.57) | $ (2.88) |
Net loss per common share, diluted | $ (1.02) | $ (1.46) | $ (2.57) | $ (2.88) |
Weighted-average number of common shares used in net loss per common share, basic | 119,316 | 106,630 | 116,594 | 102,349 |
Weighted-average number of common shares used in net loss per common share, diluted | 119,316 | 106,630 | 116,594 | 102,349 |
Product Revenue, Net [Member] | ||||
Revenue: | ||||
Revenue | $ 89,645 | $ 15,654 | $ 128,444 | $ 27,763 |
Licensing and other revenue [Member] | ||||
Revenue: | ||||
Revenue | $ 5,324 | $ 668 | $ 11,370 | $ 2,940 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 616,259 | $ 551,801 |
Accounts receivable | 110,913 | 7,727 |
Inventory | 103,216 | 85,714 |
Prepaid assets | 34,404 | 36,350 |
Restricted cash | 1,085 | 1,273 |
Other current assets | 26,809 | 36,658 |
Total current assets | 892,686 | 719,523 |
Non-current assets: | ||
Right-of-use assets | 16,726 | 18,747 |
Property and equipment, net | 5,339 | 6,148 |
Other assets | 827 | 15,799 |
Total assets | 915,578 | 760,217 |
Current liabilities: | ||
Accounts payable | 27,500 | 37,342 |
Accrued expenses | 97,716 | 95,139 |
Current portion of development liability | 43,769 | 29,504 |
Current portion of right-of-use liabilities | 5,852 | 5,625 |
Total current liabilities | 174,837 | 167,610 |
Long-term liabilities: | ||
Long-term development liability | 289,960 | 315,647 |
Convertible senior notes | 92,883 | 92,736 |
Right-of-use liabilities | 12,066 | 14,352 |
Other liabilities | 429 | |
Total liabilities | 570,175 | 590,345 |
Stockholders' equity: | ||
Preferred stock, $0.0001 par value; 10,000 shares authorized, and zero shares issued and outstanding at June 30, 2023 and December 31, 2022 | 0 | 0 |
Common stock, $0.0001 par value; 200,000 shares authorized at June 30, 2023 and December 31, 2022; 117,579 shares issued and outstanding at June 30, 2023, and 110,772 shares issued and outstanding at December 31, 2022 | 12 | 11 |
Additional paid-in capital | 2,954,862 | 2,479,596 |
Accumulated other comprehensive loss | (796) | (875) |
Accumulated deficit | (2,608,675) | (2,308,860) |
Total stockholders' equity | 345,403 | 169,872 |
Total liabilities and stockholders' equity | $ 915,578 | $ 760,217 |